REASSESSMENT DYNAMICS OF ORPHAN DRUGS IN GERMANY'S BENEFIT ASSESSMENT PROCESS

被引：0
|
作者：
Chavez, D. [1 ]
Tolkmitt, F. [2 ]
Mills, M. [2 ]
Kanavos, P. [1 ]
机构：
[1] London Sch Econ & Polit Sci, London, England
[2] Hive Hlth Optimum Ltd, London, England
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PT7
引用
收藏
页码：S323 / S323
页数：1
相关论文
共 50 条
  • [41] Results of health technology assessments of orphan drugs in Germany-lack of added benefit, evidence gaps, and persisting unmet medical needs
    Kranz, Philip
    Mcgauran, Natalie
    Uenal, Can
    Kaiser, Thomas
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2024, 40 (01)
  • [42] Critical Assessment of Belgian Reimbursement Dossiers of Orphan Drugs
    Denis, Alain
    Mergaert, Lut
    Fostier, Christel
    Cleemput, Irina
    Hulstaert, Frank
    Simoens, Steven
    PHARMACOECONOMICS, 2011, 29 (10) : 883 - 893
  • [43] Critical Assessment of Belgian Reimbursement Dossiers of Orphan Drugs
    Alain Denis
    Lut Mergaert
    Christel Fostier
    Irina Cleemput
    Frank Hulstaert
    Steven Simoens
    PharmacoEconomics, 2011, 29 : 883 - 893
  • [44] Methods and criteria for the assessment of orphan drugs: a scoping review
    Mohammadshahi, Marita
    Olyaeemanesh, Alireza
    Ehsani-Chimeh, Elham
    Mobinizadeh, Mohammadreza
    Fakoorfard, Zeinab
    Akbari Sari, Ali
    Aghighi, Mohammad
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2022, 38 (01)
  • [45] ORPHAN DRUGS: HEALTH TECHNOLOGY ASSESSMENT AND PRICING IN EUROPE
    Jaroslawski, S.
    Toumi, M.
    Korchagina, D.
    Jadot, G.
    VALUE IN HEALTH, 2018, 21 : S24 - S24
  • [46] Process methods and methods to utility assessment of medical drugs in Germany - job assessments
    Koch, Klaus
    Lange, Stefan
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2009, 134 (07) : 317 - 319
  • [47] PHARMACOECONOMIC EVALUATION OF ORPHAN DRUGS IN THE UNITED KINGDOM, FRANCE, ITALY, TURKEY AND EXPLORATION OF THE EVALUATION PROCESS OF ORPHAN DRUGS IN ALGERIA
    Kebaili, H.
    Djahdou, Z.
    Amrani, I
    VALUE IN HEALTH, 2022, 25 (12) : S235 - S235
  • [48] FDA's Flexibility in the Approval of Orphan Drugs
    Pariser, Anne
    Bauer, Larry
    DRUG INFORMATION JOURNAL, 2012, 46 (04): : 404 - 404
  • [49] FDA’s Flexibility in the Approval of Orphan Drugs
    Anne Pariser
    Larry Bauer
    Drug information journal : DIJ / Drug Information Association, 2012, 46 : 404 - 404
  • [50] Orphan drugs revisited: author's response
    Hughes, D
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2006, 99 (05) : 350 - 351
12345